Changes in the upper part of the spinal cord may help identify people with relapsing-remitting multiple sclerosis (RRMS) who…
Articles by Lila Levinson, PhD
A genetic mutation associated with more severe disability in multiple sclerosis (MS) may also correlate with poorer cognitive performance…
Despite being converted into the same active ingredient, the newer multiple sclerosis (MS) drug Vumerity (diroximel fumarate) is…
An international trial will test a combined approach to targeting underrecognized cognitive symptoms of multiple sclerosis (MS), coaching patients on…
The first participant has been dosed in an investigator-initiated Phase 2 clinical trial testing Neuraly‘s experimental medication pegsebrenatide as…
The experimental drug fenebrutinib was shown to significantly outperform Aubagio (teriflunomide), an approved therapy, in reducing relapses and…
Medicaid coverage of highly effective disease-modifying therapies (DMTs) for multiple sclerosis (MS) varies across the U.S., with some…
People with multiple sclerosis (MS) who engage in more physical activity tend to have less severe physical and cognitive…
Bazedoxifene, a medication that alters the activity of the sex hormone estrogen, was safe and well-tolerated but did not promote…
Better adherence to a Mediterranean-like diet may help prevent disability worsening in people with early multiple sclerosis (MS),…
The complement system — part of the immune system that helps defend against infections — may play a key role…
Most children with multiple sclerosis (MS) have chronic active lesions that slowly get bigger over time, and their frequency…
Enrollment is complete for a Phase 2 trial testing Zenas Biopharma’s obexelimab in people with relapsing forms of…
People with multiple sclerosis (MS) may be significantly more likely to have relapses if their Medicare insurance covers fewer…
People with multiple sclerosis (MS) have a significantly greater risk of developing dementia compared with the general population, according…
Task-oriented training may help balance issues for people with multiple sclerosis (MS), particularly when combined with conventional physiotherapy, according…
Among people in New Zealand, the proportion of individuals with multiple sclerosis (MS) — the disease’s prevalence, or how…
People with multiple sclerosis (MS) who have chronic lower body pain show distinct changes in how they walk, including…
Alvotech, a developer of biosimilar medicines, is expanding its partnership with Advanz Pharma to commercialize three new products…
Children with pediatric-onset multiple sclerosis (MS) tend to use more healthcare resources than their peers, starting from birth and…
As a whole, disease-modifying therapies (DMTs) for multiple sclerosis (MS) tend to reduce the risk of stroke among…
Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting and progressive forms of multiple sclerosis (MS), a study…
MS Canada is inviting people across the country to support the multiple sclerosis (MS) community and help raise…
Factors including being male, smoking, and having more frequent relapses are linked to significantly increased risk of disease progression in…
Quantum Biopharma has signed an agreement with a global pharmaceutical contract research organization to continue advancing Lucid-21-302, its experimental…
Supervised, noninvasive at-home neural stimulation helped women with multiple sclerosis (MS) and cannabis use disorder (CUD) decrease their cannabis…
Women with multiple sclerosis (MS) who have a close friend to confide in experience better physical and mental health…
The signaling molecule interleukin-6 (IL-6), which is involved in inflammation, is associated with increasing frailty in people with multiple…
The use of high-efficacy disease modifying therapies (DMTs) among relapsing-remitting multiple sclerosis (RRMS) patients may aid their capacity to…
United Healthcare will reimburse the cost of the PoNS device, which uses electrical stimulation to improve walking, for…